Amyloid Imaging in Mild Cognitive Impairment Subtypes

OBJECTIVE: We utilized the amyloid imaging ligand Pittsburgh Compound-B (PiB) to determine the presence of AD pathology in different MCI subtypes and to relate elevated PiB binding to other markers of early AD and longitudinal outcome. METHODS: Twenty-six patients with MCI – 13 single domain amnesti...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Wolk, David A., Price, Julie C., Saxton, Judy A., Snitz, Beth E., James, Jeffrey A., Lopez, Oscar L., Aizenstein, Howard J., Cohen, Ann D., Weissfeld, Lisa A., Mathis, Chester A., Klunk, William E., DeKosky, Steven T.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2009
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2828870/
https://ncbi.nlm.nih.gov/pubmed/19475670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.21598
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia